Related Experiment Video
Updated: May 12, 2026

Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
Comparative Analysis of Mucosa-Associated and Luminal Gut Microbiota in Pediatric Ulcerative Colitis
Takeo Kondo1, Sonoko Kondo1, Haruyuki Nakayama-Imaohji2
1Department of Pediatrics, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki, Kita, Kagawa 761-0793, Japan.
Insights
Pediatric ulcerative colitis (UC) disrupts the gut's mucosal-associated microbiota (MAM), making it similar to fecal bacteria. This indicates a compromised mucus barrier, potentially aiding in UC prognosis evaluation.
Area of Science:
- Gastroenterology
- Microbiology
- Pediatric Medicine
Background:
- Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn's disease, are linked to gut microbiota dysbiosis.
- Severe pancolitis is more common in pediatric UC than adult UC.
- Alterations in colon mucosa-associated microbiota (MAM) and their link to disease severity in pediatric UC require further investigation.
Purpose of the Study:
- To compare gut microbiota in colon lavage fluids (CLFs) and fecal samples from pediatric UC patients and non-IBD controls.
- To investigate the association between MAM composition, disease severity, and mucus barrier integrity in pediatric UC.
Main Methods:
- 16S metagenomic analysis of colon lavage fluids (CLFs) and fecal samples from 19 pediatric UC patients and 19 non-IBD controls.
- Comparison of MAM community structure and bacterial composition between different colonic locations and between MAM and fecal samples.
- Assessment of MAM distribution and its relationship with disease activity and mucosal inflammation.
Main Results:
- MAM community structure was similar throughout the colon in both groups.
- In non-IBD individuals, MAM and fecal bacterial compositions differed significantly, but not in pediatric UC patients, suggesting a compromised mucus barrier in UC.
- In pediatric UC, MAM distribution became disordered with increased disease activity, showing higher abundance of bacteria from the upper digestive tract or environmental origins.
- Key bacterial markers like increased *Lactobacillus* and *Enterococcus*, or decreased *Faecalibacterium* and *Blautia* were observed in pediatric UC MAM.
Conclusions:
- The study highlights a compromised mucus barrier in pediatric UC, leading to MAM and fecal microbiota intermixing.
- Disordered MAM and the presence of aberrant bacteria correlate with disease activity in pediatric UC.
- Monitoring specific bacterial markers in MAM may offer a valuable tool for evaluating prognosis in pediatric UC patients.
Abstract:
Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn's disease, are chronic disorders relating to gut microbiota dysbiosis. Despite severe pancolitis being more prevalent in pediatric UC than in adults, alterations in the colon mucosa-associated microbiota (MAM) and their association with disease severity remain to be elucidated. The present study aimed to compare the gut microbiota in colon lavage fluids (CLFs) and fecal samples from 19 pediatric UC and 19 non-IBD patients. The community structure of MAM inferred by 16S metagenomic analysis was similar throughout the colon regardless of disease type. Bacterial compositions between MAM and feces were significantly different in non-IBD, while no difference was observed in pediatric UC, indicating a compromised mucous layer that could not sufficiently separate the MAM and luminal microbiota in UC. In pediatric UC, homogenous distribution of MAM was gradually disordered with increases in disease activity or mucosal inflammation, and bacterial groups of upper digestive tract or environmental origin were more abundant in MAM. Monitoring key bacterial markers in MAM, which include Lactobacillus and Enterococcus or Faecalibacterium and Blautia as increased or reduced members in pediatric UC, respectively, might be useful for evaluation of patient prognosis.
Related Concept Videos
Introduction to the Human Microbiota
Development of Human Microbiota
Microbiota of the Stomach and Small Intestine
Microbiota of the Large Intestine
Inflammatory Bowel Disease II: Ulcerative Colitis

